Iliac venous outflow obstruction has an important role in the expression of symptomatic chronic venous insufficiency. This anatomic obstruction is frequently overlooked, owing in part to diagnostic ...

Stenting of iliac artery disease in patients with severely calcified lesions or extensive peripheral artery disease (PAD)—who historically have been excluded from clinical trials—is safe and effective ...

NATICK, Mass., Oct. 23, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports twelve-month clinical endpoint data from the ORION trial, which demonstrated robust safety and ...

For women with subsequent pregnancy, iliac vein stents demonstrate good peripregnancy and postpregnancy stent patency, according to a study published online in the March 1 issue of the Journal of ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — Approved by the FDA in late January, the first balloon-expandable stent graft with an ...

The US Food and Drug Administration (FDA) has approved Abbott's Absolute Pro Vascular Self-Expanding Stent System for the treatment of iliac artery disease, a form of peripheral artery disease (PAD) ...

Abbott's MOBILITY study supported the approval--a prospective, non-randomized, two-arm multi-center study conducted at 48 U.S. sites with 304 patients. Abbott compared its Omnilink Elite to its ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Patients who underwent primary stenting guided by IVUS ...

NATICK, Mass. and MIAMI, Jan. 16, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) reports nine-month clinical endpoint data from its ORION trial, demonstrating excellent outcomes for ...

The major obstacle for precise selection of patients for venous outflow stenting is the lack of a reliable test to measure a hemodynamically significant stenosis. The key for the physician is to be ...

Twelve-Month Data Presented at TCT 2012 Support Safety and Efficacy of Epic Stent in Iliac Stenting NATICK, Mass. -- Boston Scientific Corporation reports twelve-month clinical endpoint data from the ...